Furosemide for Accelerated Recovery of Blood Pressure Postpartum
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 384 participants.
Also called NCT03556761
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 384 participants
- Sponsor
- Registry
-
NCT03556761
-
- Other papers using this trial's data
- Furosemide for Accelerated Recovery of Blood Pressure Postpartum in women with a hypertensive disorder of pregnancy: A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03556761. Randomized; quadruple masking; primary purpose prevention. Start 2018-06-20 (actual); primary completion 2019-12-04 (actual). Results posted on 2020-09-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Furosemide for Accelerated Recovery of Blood Pressure Postpartum
- Acronym
- ForBP
- Condition
- Hypertension, Pregnancy-Induced
- Intervention (Drug)
- Oral furosemide
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- University of Pennsylvania
Record details
- Record id
cardio:ct-nct03556761- Content hash
aa113baa3b41576e763db61cdf17c14bf423e9c10b03ac138b5a24dc55c1f6cd